Table 2.
Measures of Adherence.
Measure | Pros | Cons |
---|---|---|
Direct | ||
Direct observation | Most accurate | Not feasible in real-world practice |
Serum drug levels | Objective measure of recent exposure to drug | Can be manipulated; acceptable ranges often unknown; assays not widely available |
Indirect | ||
Pill counts | Inexpensive | Difficult in real-world practice; easy to manipulate; may overestimate adherence; demeaning |
MEMS (microelectronic event monitoring system) | Accurate data on when one opens the bottle; may be combined with reminder systems | Not easily feasible in real-world practice; expensive |
Refill records | Objective higher level data; good for research purposes | Report fill rate and not actual intake; impractical for daily use |
Biomarkers | May be important intermediaries to outcomes (e.g., hypertension with TKI use) | Few developed and validated |
Outcomes | Most important variable | Difficult to discern nuances of adherence outside of clear extremes |
Indirect and Subjective | ||
Self-report | Quick; can use past validated instruments; does not require clinician time | Subject to significant bias such as the Hawthorne effect and overestimates adherence |
Assessment by others | Inexpensive; allows for a dialogue | Hawthorne effect; time consuming |
Diaries | Inexpensive; actively involves the patient | Subject to manipulation; demeaning; time consuming |